Are peptides legal in Poland?
The short answer
In Poland, peptide medicines that hold a marketing authorisation, in particular the GLP-1 analogues semaglutide and tirzepatide, are lawful but available only on prescription, and prescription medicines cannot be bought legally online. The Chief Sanitary Inspector and the Chief Pharmaceutical Inspector warn that offering synthetic peptides for sale as chemical reagents or research materials in the way they describe is contrary to Polish law and can bring criminal liability, and in a separate decision of October 2024 the Chief Pharmaceutical Inspector withdrew seven named products offered for general sale on the website www.peptiline.pl, whose presentation and descriptions attributed medicinal indications to them although they held no marketing authorisation. Peptide hormones and growth factors also sit in class S2 of the prohibited list in sport, which is binding at all times; this is general information, not legal advice.
Status by category
| Category | Status |
|---|---|
| Approved peptide medicines | Prescription only |
| Research peptides | Prohibited |
| Compounded preparations | Unclear |
| Cosmetics | Not regulated as a medicine |
| Food supplements | Unclear |
| Personal import | Restricted |
| Sport and anti-doping | Prohibited |
Approved peptide medicines Prescription only
GLP-1 analogues such as semaglutide and tirzepatide are described by the regulators as legally available only on prescription and to be used under medical supervision. Prescription medicines cannot be bought legally online: an online pharmacy may deliver only non-prescription medicines, while a reserved prescription medicine is collected in a physical pharmacy on presentation of a valid prescription. Falsified versions of these medicines are offered on illegal websites and social media. [3]
Research peptides Prohibited
Synthetic peptides sold online as chemical reagents for analytical testing, as reference materials for laboratory use only or as products for research and development have no medicinal product status and have not passed clinical trials, and they may not be sold for medical purposes. The Chief Sanitary Inspector and the Chief Pharmaceutical Inspector state that offering them for sale in the way they describe is contrary to the law in force in Poland and risks criminal liability. The sources set out no rule on simple possession, and the authorities ask people not to take substances that are not intended for human use. [2]
Compounded preparations Unclear
No specific official rule found.
Cosmetics Not regulated as a medicine
A cosmetic product is any substance or mixture intended for contact with the external parts of the human body, or with the teeth and the mucous membranes of the oral cavity, whose sole or main purpose is keeping them clean, perfuming, changing their appearance, protecting them, keeping them in good condition or correcting body odour. It is notified in the European CPNP database, products made available in Poland must be labelled in Polish, and notification in CPNP does not by itself confirm that the product qualifies as a cosmetic, that it may be marketed, or that it is safe. Where a product meets at the same time the criteria of a medicinal product, by reason of the properties of the active substance and its intended purpose, and the criteria of a cosmetic, pharmaceutical law applies. [8][1]
Food supplements Unclear
Foods with added vitamins, minerals or substances listed in Annex III parts B and C of Regulation 1925/2006 must be notified to the Chief Sanitary Inspector when placed on the Polish market for the first time, and the notification must give the qualitative and quantitative composition, including active substances. The sources describe this notification duty but name no peptide, so no peptide-specific rule for food supplements was found in them. [7]
Personal import Restricted
People carrying their own medicines should hold a medical certificate confirming that they need to use them. Current rules allow bringing into Poland for personal use no more than 5 packages of a medicinal product, provided it contains no narcotic or psychotropic substances, and a medicine brought from abroad for personal use may not be resold to anyone, which is punishable. For prescription medicines such as GLP-1 analogues, the regulators state they are legally available only on prescription. [4][3]
Sport and anti-doping Prohibited
The Polish Anti-Doping Agency applies the International Standard Prohibited List, updated every year by WADA, and states that the list is absolutely binding. Class S2, peptide hormones, growth factors, related substances and mimetics, is in the group prohibited at all times. The regulators add that many substances sold as research peptides are synthetic hormones or growth factors on that list, and that athletes using them can be disqualified and face legal liability. [5][2]
Peptide by peptide
| Peptide | Status | Details |
|---|---|---|
| semaglutide | Prescription only | Named by GIF and URPL as a GLP-1 analogue legally available only on prescription. [3] |
| tirzepatide | Prescription only | Named by GIF and URPL as a GLP-1 analogue legally available only on prescription. [3] |
| retatrutide | Unclear | No specific official rule found. |
| BPC-157 | Not authorised | Named in the GIF decision withdrawing from the market products offered for sale on the website www.peptiline.pl, as a medicinal product that was never authorised. [1] |
| TB-500 (thymosin beta-4) | Unclear | No specific official rule found. |
| GHK-Cu | Not authorised | Named in the GIF decision withdrawing from the market products offered for sale on the website www.peptiline.pl, as a medicinal product that was never authorised. [1] |
| CJC-1295 | Not authorised | Named in the GIF decision withdrawing the products CJC1295+DAC and CJC+DAC offered for sale on the website www.peptiline.pl, as medicinal products that were never authorised. [1] |
| GHRP-2 | Not authorised | Named in the GIF decision withdrawing from the market products offered for sale on the website www.peptiline.pl, as a medicinal product that was never authorised. [1] |
| Semax | Not authorised | Named in the GIF decision withdrawing from the market products offered for sale on the website www.peptiline.pl, as a medicinal product that was never authorised. [1] |
| ipamorelin | Unclear | No specific official rule found. |
| melanotan II | Unclear | No specific official rule found. |
| PT-141 (bremelanotide) | Unclear | No specific official rule found. |
| AOD-9604 | Unclear | No specific official rule found. |
| MOTS-c | Unclear | No specific official rule found. |
| epitalon | Unclear | No specific official rule found. |
| sermorelin | Unclear | No specific official rule found. |
| tesamorelin | Unclear | No specific official rule found. |
Change history
- The Chief Pharmaceutical Inspector decided to withdraw from the market in Poland the products CJC1295+DAC, SEMAX, ADAMAX, BPC-157, GHRP-2, GHK-CU and CJC+DAC offered for general sale on the website www.peptiline.pl. The presentation of those products suggested therapeutic action and their descriptions attributed to them properties of preventing or treating human disease, or of restoring, improving or modifying physiological functions, so they met the definition of a medicinal product while holding no marketing authorisation. The decision was given immediate enforceability. [1]
- The Chief Sanitary Inspector and the Chief Pharmaceutical Inspector published a joint public warning on illegal trade in synthetic peptides offered as chemical reagents or for research, stating that selling them in this way is contrary to Polish law and can bring criminal liability. [2]
- GIF and the President of URPL warned about the sharp rise in falsified medicines sold online in the European Union, in particular GLP-1 analogues used for weight reduction and diabetes, and restated that these substances are legally available only on prescription. [3]
- A new WADA list of prohibited substances and methods came into force, as announced by the Polish Anti-Doping Agency. Peptide hormones, growth factors, related substances and mimetics remain in class S2, prohibited at all times. [5]
Official sources
- Wycofanie z obrotu produktów: „CJC1295+DAC”, „SEMAX”, „ADAMAX”, „BPC-157”, „GHRP-2”, „GHK-CU” i „CJC+DAC”, Główny Inspektorat Farmaceutyczny (GIF)
- Ostrzeżenie publiczne. Nielegalny obrót syntetycznymi peptydami oferowanymi jako odczynniki chemiczne lub do badań (07.08.2025), Główny Inspektor Sanitarny i Główny Inspektor Farmaceutyczny (GIS / GIF)
- Rośnie zagrożenie sfałszowanymi lekami na cukrzycę i chorobę otyłościową (08.09.2025), Główny Inspektorat Farmaceutyczny (GIF)
- Przywóz leków na własny użytek, Główny Inspektorat Farmaceutyczny (GIF)
- Lista Substancji i Metod Zabronionych (Międzynarodowy Standard), Polska Agencja Antydopingowa (POLADA)
- Rozporządzenie Ministra Zdrowia w sprawie wykazu leków, które mogą być traktowane jako surowce farmaceutyczne przy sporządzaniu leków recepturowych (Dz.U. 2012 poz. 1259, tekst HTML), Dziennik Ustaw / eli.gov.pl (Rządowe Centrum Legislacji)
- Elektroniczny system powiadomień: powiadomienie o wprowadzeniu po raz pierwszy do obrotu (suplementy diety, żywność wzbogacana), Główny Inspektorat Sanitarny (GIS)
- Produkty kosmetyczne: informacje ogólne (CPNP, raport bezpieczeństwa, nadzór), Główny Inspektorat Sanitarny (GIS)
General information, not legal advice. Rules change: check the official source before you act.